|Institutional Source||Beutler Lab|
|Gene Name||FBJ osteosarcoma oncogene|
|Synonyms||cFos, D12Rfj1, c-fos|
|Is this an essential gene?||Essential (E-score: 1.000)|
|Stock #||R7154 (G1)|
|Chromosomal Location||85473890-85477273 bp(+) (GRCm38)|
|Type of Mutation||missense|
|DNA Base Change (assembly)||A to T at 85474157 bp|
|Amino Acid Change||Methionine to Leucine at position 40 (M40L)|
|Ref Sequence||ENSEMBL: ENSMUSP00000021674 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000021674]|
|Predicted Effect||probably benign
AA Change: M40L
PolyPhen 2 Score 0.001 (Sensitivity: 0.99; Specificity: 0.15)
AA Change: M40L
|Coding Region Coverage||
|Validation Efficiency||100% (67/67)|
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The Fos gene family consists of 4 members: FOS, FOSB, FOSL1, and FOSL2. These genes encode leucine zipper proteins that can dimerize with proteins of the JUN family, thereby forming the transcription factor complex AP-1. As such, the FOS proteins have been implicated as regulators of cell proliferation, differentiation, and transformation. In some cases, expression of the FOS gene has also been associated with apoptotic cell death. [provided by RefSeq, Jul 2008]
PHENOTYPE: Null mutants are growth-retarded, most dying perinatally. Survivors have osteopetrosis and abnormal tooth eruption, gametogenesis, hemopoiesis, behavior and photoreceptor apoptosis. Hippocampal-specific mutants have seizures and highly excitable neurons. [provided by MGI curators]
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Fos||
(F):5'- TACTACTCCAACCGCGACTG -3'
(R):5'- TATGACAAGTGTGCACGCG -3'
(F):5'- TTCCGCGAACGAGCAGTG -3'
(R):5'- TCAGACAAGTCCTGGGTTCC -3'